-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Market Perform on Revolution Medicines, Raises Price Target to $179

Benzinga·08/21/2026 13:39:37
Listen to the news
Bernstein analyst Jeffrey Walch maintains Revolution Medicines (NASDAQ:RVMD) with a Market Perform and raises the price target from $151 to $179.